Jailani, Samera M.
HRN: 27-93-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2025
CEFUROXIME 750MG (VIAL)
12/31/2025
01/07/2026
SIV
330mg
Q8h
Rule Out UTI, SVI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes